MarylandAre you in Maryland?
Change location

Web privacy policy

We take your privacy seriously, and we want you to know how we collect, use, share and protect your information.

This policy applies to Mapviser.com.


What information we collect

Information you give us: We respect the right to privacy of all visitors to the Mapviser.com.

We receive and store information you enter on our site or give us in any other way, such as name, email address and phone number. This includes information you submit on forms, such as appointment request forms. Some forms collect sensitive information, such as health information, necessary for us to provide our services to you.

Information we collect automatically: When you interact with our sites and email newsletters, certain information about your use of our sites and interaction with our email newsletters is automatically collected. This information includes computer and connection information, such as statistics on your page views, traffic to and from our sites, referral URL, ad data, your IP address, and device identifiers. This information also may include your transaction history, and your web log information, how you search for our sites, the websites you click on from our sites or emails, whether and when you open our emails, and your browsing activities across other websites.

Much of this information is collected through cookies, web beacons and other tracking technologies, as well as through your web browser or device (e.g., IP address, MAC address, browser version, etc.).

Email communications, newsletter and related services


We use the information we collect for things like:

Optimizing the performance and user experience of our sites

  • Operating, evaluating and improving our business.
  • Fulfilling orders and requests for products, services or information.
  • Processing returns and exchanges.
  • Tracking and confirming online orders.
  • Delivering or installing products.
  • Marketing and advertising products and services, including by inferring your interests from your interactions with our websites and newsletters, and tailoring advertisements, newsletters, and offers to you (both on our websites and on other websites) based on your interactions with us in our stores and online interests.
  • Sending you email newsletters.
  • Conducting research and analysis.
  • Communicating with you about your account, special events and surveys.
  • Establishing and managing your accounts with us.

Data retention

We will retain your information for as long as your account is active or as needed to provide you services, comply with our legal obligations, resolve disputes and enforce our agreements.

We may share information with third parties.

We may share the information we collect about you with third parties who we have engaged to help us provide the services, or they may collect information about you directly when you interact with them.

Third parties may collect information such as IP addresses, traffic patterns and related information. This data reflects site-usage patterns gathered during visits to our website each month or newsletter subscribers' interactions with our newsletters.

We may also use or disclose your personal information if required to do so by law or on the good-faith belief that such action is necessary to (a) conform to applicable law or comply with legal process served on us or our sites; (b) protect and defend our rights or property, the sites, or our users; or (c) act to protect the personal safety of us, users of the sites or the public.


Protecting children's privacy

We are committed to protecting children's privacy on the internet, and we do not knowingly collect personal information from children.


Links to other websites

Our websites link to other websites, many of which have their own privacy policies. Be sure to review the privacy policy on the site you're visiting.

Diseases

Select one category
Dermatology
Immune system
Lungs & pulmonary
Bones Muscles Joints
Digestive
Hormones
Kidney & bladder
Sex & reproductive
Mouth & Dental
Brain & Nervous System
Heart & Blood Vessels
Ear, Nose And Throat
Skin & cosmetic
Eyes & vision
All category
Find a disease by its first letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Iritis

Iritis is a term describing inflammation of the eye structures surrounding iris. Iritis is used interchangeably with another condition called anterior uveitis. Uveitis is more involved inflammation of the eye that can affect the optic nerve, sclera, and retina. In a way, this terminology is important to the ophthalmologists to describe the segments of the eye that are inflamed.

In this article:


Iritis Treatment

Treatment aims at eliminating inflammation and pain with steroids and topical cycloplegics. The main goal is to prevent complications and blindness. Any additional therapies depend on associated processes. For example, anti-viral medications are necessary in herpetic uveitis, while bactrim can be used in toxoplasmic chorioretinitis.

Antimetabolite, biologics, and other immunosuppressive medications (e.g., methotrexate, azathioprine, mycophenolate, cyclosporine, adalimumab, and infliximab) are often necessary for chronic, non-infectious cases, especially in cases associated with systemic inflammatory diseases.  However, these agents should only be prescribed by doctor specifically trained in their use and attuned to their side effect profile.


Medical treatment of Iritis

For anterior uveitis therapy consists of topical corticosteroids and cycloplegics.  Steroids should be tapered according to clinical response to minimize rebound inflammation.

People should return for a scheduled follow-up after 1 week of treatment with corticosteroids. During this visit and each subsequent visit, the number of anterior chamber cells/high-power field (HPF) should be half of what it was at the initial examination. If the number of cells is not decreasing, then the primary eye care practitioner should suspect one of two things: the patient is either not using the drops correctly, or an infection should be suspected, such as herpes.

Cycloplegics, typically atropine or cyclogyl, are used to minimize pain by reducing spasm of the ciliary body and prevent and/or lyse posterior synechiae (adhesions of the iris to the lens capsule).  These medications are typically applied twice daily until inflammation has resolved or has significantly decreased before cessation.


Drugs to treat iritis

Initial treatment of anterior uveitis involves topical corticosteroids. The most common topical corticosteroid prescribed for the treatment of anterior uveitis is prednisolone acetate 1%, followed by dexamethasone 0.1% and prednisolone sodium phosphate 1%. Ophthalmologist needs to monitor a person for resolution of inflammation and measure intraocular pressure if prolonged topical steroid used.

Viral iritis treatment: to reduce an inflammation and heal tissues of the eye doctor prescribes a combination regimen: Oral acyclovir, topical corticosteroids, and cycloplegics/mydriatic agents. In severe and recurrent disease, maintenance therapy of oral acyclovir is useful to prevent a relapse. Alternatively, valacyclovir may also be used.

Systemic antiviral therapy combined with low-dose corticosteroid drops may have to be used for several years, to prevent relapses. For people with raised intraocular pressure antiglaucoma medications are given topically.

Severe elevation of IOP may require oral carbonic anhydrase inhibitors and filtration surgery.

Resistance of herpes simplex virus (HSV) to acyclovir and cytomegalovirus (CMV) to ganciclovir is a recently reported phenomenon. HSV resistance to acyclovir occurs due to specific mutations in the viral thymidine kinase, mutations in the viral DNA polymerase gene, HSV having a deficient thymidine kinase protein or the natural hypervariability of HSV thymidine kinase gene.

Acyclovir resistant HSV strains also show some amount of cross-resistance to ganciclovir which has implications in management of these patients. Use of cidofovir and foscarnet is recommended to treat acyclovir resistant HSV anterior uveitis.

Brimonidine should be used with caution to treat high IOP in patients of viral anterior uveitis. Brimonidine may cause granulomatous anterior uveitis which may mimic recurrence of viral anterior uveitis. This side-effect may present with or without symptoms, usually many months after initiation of treatment. It may occur only in unilaterally and is fully reversible once brimonidine is withdrawn.


Iritis treatment at home

Self-treatment of iritis is not recommended due to potential of vision loss. At home you should strictly follow recommended by a specialist treatment. It is also important to shake the steroid suspension as failure to do so may result in a subtherapuetic response.

Usually, hourly instillation of topical corticosteroids with weekly follow-up visits until there are five or fewer cells/HPF. Once five or fewer cells/HPF are present in the anterior chamber, the frequency of drop instillation should be reduced to every 2 hours.
Follow-up care for iritis

Uveitis is a condition that can present in emergency departments or primary care settings.  It is important to recognize symptoms and make an accurate diagnosis.  It is vital for primary care providers to refer the patient to an ophthalmologist if uveitis is suspected.

Treatment for uveitis should be handled by an interprofessional team approach that includes:

  • ophthalmologists
  • retina and uveitis specialists
  • specialty-trained nurses
  • rheumatologist or allergist (for systemic disease)
  • pharmacists

It is very important to have continuous care by an ophthalmologist, as in many cases systemic disease can relapse causing vision loss.


Iritis Complications

Prolonged or undertreated intraocular inflammation can lead to pathological changes in the eye resulting in permanent vision loss.  These complications include:

  • cataracts
  • iris adhesions,
  • epiretinal membrane (ERM),
  • cystoid macular edema (CME)
  • band keratopathy,
  • hypotony,
  • glaucoma,
  • optic nerve edema

References

Viral anterior uveitis. Babu K, Konana VK, Ganesh SK, Patnaik G, Chan NSW,Chee SP, Sobolewska B, Zierhut M.IndianJ Ophthalmol. 2020 Sep;68(9):1764-1773. doi: 10.4103/ijo.IJO_928_20.PMID:32823392Free PMC article.Review.

Iritis. Mahabadi N, Kim J, Edens MA.2021 Jul 26. In: StatPearls[Internet].Treasure Island (FL): StatPearls Publishing; 2021 Jan–.PMID:28613659FreeBooks & Documents.Review.

Diagnosis and treatment of anterior uveitis: optometric management. Harthan JS,Opitz DL, Fromstein SR, Morettin CE.Clin Optom (Auckl). 2016 Mar 31;8:23-35.doi: 10.2147/OPTO.S72079. eCollection 2016.PMID:30214346Free PMCarticle.Review.

Advances in the treatment of uveitis in patients with spondyloarthritis – is it the time for biologic therapy? Mitulescu TC, Trandafir M, Dimăncescu MG, CiuluvicăRC, Popescu V, Predețeanu D, Istrate S, Voinea LM.Rom J Ophthalmol. 2018 Apr-Jun;62(2):114-122.PMID:30206554Free PMC article.Review.

Find pros in all 51 states

AlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutDelawareDistrict of Columbia
FloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentucky
LouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontana
NebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaOhio
OklahomaOregonPennsylvaniaRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtah
VermontVirginiaWashingtonWest VirginiaWisconsinWyoming
AlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutDelawareDistrict of Columbia
FloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentucky
LouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontana
NebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaOhio